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Vulvar diseasesVulvodynia is a poorly recognized entity by clinicians – even by
those who deal with female sexual health. While the study of
vulvovaginal diseases, including pain disorders, is included inmost res-
idency programs in North America, it is acknowledged that clinical ex-
posure may be insufficient. The scenario in the rest of the world is
probably no better [1].
Vulvodynia affects at least 6% of women (up to 20% in some series),
and can be found at any age and in all ethnic groups [2,3]. The disease is
common and dramatically affects quality of life, beyond the obvious
sexual aspect [4]. The importance of investigating vulvar symptoms
even in younger women is underlined by studies reporting that the
prevalence of vulvodynia among adolescents is similar to that among
adult women [5].
The International Society for the Study of Vulvovaginal Disease
(ISSVD) defined vulvodynia as vulvar pain of at least 3 months' dura-
tion, without clear identifiable cause, which may have potential associ-
ated factors– or, more simply, idiopathic vulvar pain [6]. It was
subdivided according to location (generalized, localized) and the need
of a stimulus to elicit the symptoms (provoked, spontaneous, or
mixed). In the terminology recommended in 2015 itwas acknowledged
that there are potential associated factors [7].
The diagnosis of vulvodynia is one of exclusion, albeit pretty
straightforward. Detection of localized sensitivity in the vulvar vesti-
bule, by using a swab,may uncover the problem. For somewomen, hav-
ing a diagnosis, a name for the disease, is highly relieving – they
commonly report that they felt the symptoms were not valued by
health care providers, or that their condition was considered to be
fake, exaggerated, or merely psychological. Interestingly, it has been
shown more generally that there is a sex bias when evaluating pain –
women's pain tends to be less valued [8–10]. After the diagnosis of
vulvodynia is made, it is fundamental to establish realistic goals, keep-
ing in mind that some of these women have been suffering for monthshttps://doi.org/10.1016/j.crwh.2018.e00079
2214-9112/© 2018 The Authors. Published by Elsevier B.V. This is an open access article underor years. Women must know in advance that the path to recovery will
have its ups and downs, and that significant improvement, rather than
cure, is the objective.
Failure to make a proper diagnosis often leads to irrelevant or dele-
terious diagnostic exams (e.g. biopsies, HPV testing) and treatments
(e.g. imiquimod, LASER, trichloroacetic acid, embolization [11]).
Vulvodynia has several different aetiologies and associated conditions,
and thus different – and unpredictable - responses to treatment. The
placebo effect is very high in the treatment of vulvodynia and sexual
dysfunction (vulvodynia is a cause of sexual dysfunction, rather than a
sexual dysfunction itself) [12–14].
When dealing with vulvodynia patients, the primum non nocere
principle must be kept in mind – in case of doubt, referral to a provider
or a team with experience in the field is advisable. Despite the usually
low levels of evidence supporting any particular intervention, treatment
measures include stoppingunnecessary topicalmedication, topical lido-
caine, anticonvulsant and antidepressive drugs, and physical therapy
[14–16]. Some women, however, will fail to improve and, in selected
cases (vestibulodynia), some will be candidates for surgery
(vestibulectomy). This is a last resort and should probably be performed
only in referral centres.
The lack of standard measures of treatment outcome prevent even
partial comparison of clinical trial results in vulvodynia [17].
The definitions are clear and the diagnosis is not difficult. Given that,
two questions naturally ensue: “why is it not diagnosed more often?”
[8] and “what can we do to improve it?”
Since the first description of vulvodynia, which goes back, at least,
to the 19th century, it has had several other designations, some of
which are still frequently encountered in the scientific literature,
such as “vestibulitis”. This is a clear example of a misleading designa-
tion, since clearly it is not an infectious or inflammatory disease. The
use of several different designations for the same condition, as well
as the inaccuracy of some of them, coupled with the lack of proper
definitions, may have slowed investigation in this field.
Some women consider that it is normal to have pain during inter-
course. Others tend to attribute the symptoms to other, better-
known conditions, or simply feel ashamed of their symptoms [8].
Too often, it is assumed that genital pain, burning, or pruritus are
due to candidosis – which is known to be wrong most of the time
[18]. On the other hand, medical knowledge of the condition may
be insufficient or there may even be some prejudice – in one study,
45.1% of women with vulvodynia felt they were being stigmatized
(somatization, excuse to avoid sex) by the health care provider
[8,19].
Womenwith vulvodynia often are incorrectly categorized as hav-
ing “vaginismus”, which does not necessarily imply pain. “Vaginis-
mus” disappeared from the Diagnostic and Statistical Manual of
Mental Disorders, 5th Edition: along with dyspareunia, it becamethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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der (GPP/PD) [20]. It became one entity, without acknowledging
the differences or the existence of vulvodynia. Following the publica-
tion of this manual, most women with vulvodynia may be
misclassified as having GPP/PD and be offered only psychological
treatment. While vulvodynia may indeed be sometimes associated
with psychological sequalae and sexual dysfunction – which defi-
nitely can benefit from a psychological approach – failing to recog-
nize there is a somatic cause for the symptoms can add to the
suffering of the woman [21,22]. Therefore, vulvodynia should also
be studied in residency programs of psychiatrists/sexologists, as
well as in the graduation programs of other mental health profes-
sionals. Women currently classified as having genito-pelvic pain/
penetration disorder should always be evaluated by an experienced
physician trained in vulvovaginal diseases and/or pelvic floor
disorders.
The diagnosis of vulvodynia is still often missed. The responsi-
bility is of both patients and health care providers. Education is
the key to change this scenario: it is mandatory to increase the
awareness of both parties. We must learn how to address sexual
health issues and how to make patients feel safe and comfortable
discussing them.
Our inability to correctly manage vulvodynia derives from a lack of
awareness. It is, however, an unfair game: when a cause is identified
for the pain, the condition is no longer called vulvodynia but rather vul-
var pain caused by a specific disorder, and a specific treatment can be
implemented.
The management of vulvodynia is difficult and often frustrating to
both parties, but we have no excuse to misdiagnose it. We may not
cure all patients, but we can make a difference in the life of most –
and those cases are rewarding. Chronic pain or burning must ring this
bell….
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